Interferon-epsilon Protects the Female Reproductive Tract from Viral and Bacterial Infection
Ka Yee Fung, Niamh E Mangan, Helen Cumming, Jay C Horvat, Jemma R Mayall, Sebastian A Stifter, Nicole De Weerd, Laila C Roisman, Jamie Rossjohn, Sarah A Robertson, John E Schjenken, Belinda Parker, Caroline E Gargett, Hong PT Nguyen, Daniel J Carr, Philip M Hansbro, Paul J Hertzog
Science | AMER ASSOC ADVANCEMENT SCIENCE | Published : 2013
Awarded by NIH
Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
We thank A. Mansell, R. Ferrero, and L. Salamonsen for their contributions; N. Bourke and S. Forster for helpful discussions and reading of the manuscript; K. Fitzgerald for reagents; and C. Berry for assistance with viral plaque assays. The data presented in this paper are tabulated in the main text and in the supplementary materials. This work was supported by funding from Australian National Health and Medical Research Council (P.J.H., N. E. M., P. M. H., J.R., C. E. G., and B. P.), the Australian Research Council (P.J.H., N. E. M., J.R.), the NIH via grant R01 AI053108 (D.J.C.), and the Victorian Government's Operational Infrastructure Support Program. P.J.H., N. E. M., K.Y.F., H. C., S. A. S., and N. D. W. hold International Patent Application number PCT/AU2011/000715, "Use of interferon epsilon in methods of diagnosis and treatment."